BioSpace News Archive

Titan Medical Inc. today announced that in view of the commencement of the strategic review process announced on November 30, 2022, the special meeting of its shareholders scheduled for January 12, 2023 will be suspended and, if appropriate and necessary, rescheduled to a future date.

1health.io Inc. (“1health”), an industry-leading software company that empowers laboratories to launch new test products quickly into both clinical and online markets, partners with Dante Genomics to help launch their whole genome sequencing test to their customers in the United States with online prescription services.